Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-16

FDA Approved: INFANTS MOTRIN — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for INFANTS MOTRIN (ibuprofen) submitted by Kenvue Brands LLC, related to changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infants Motrin (Ibuprofen)

Snippet

SUPPL AP for INFANTS MOTRIN (IBUPROFEN)